Google
CDXS 株価分析 — Codexis Inc (Healthcare >> Biotechnology)
CDXS に関するよくある質問
CDXSのPER（株価収益率）は？
Codexis Inc（CDXS）は現在PER 16.58倍で取引されています。
CDXSのROE（自己資本利益率）は？
Codexis IncのROEは-73.99%です。
CDXSの配当利回りは？
Codexis Incの配当利回りは0.00%です。
CDXSの品質スコア（Quality Score）は？
当社のAIはCDXSの総合財務品質を100点中62点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
CDXSは今が買い時ですか？
当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
CDXSはどのセクターに属しますか？
Codexis IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）
CDXS AI Analysis Summary
Our AI summary for CDXS: Codexis Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 16.58, ROE of -73.99%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 1.40
Price
-0.08
(-5.41%)
Day Change
|
|
|---|
CDXS, ファンダメンタルスコアはok ( ファンダメンタル = 62) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.40 |
| PBV / Sector |
3.68 / 5.20
|
| Earning Per Share | -0.28 |
| PE / Sector |
16.58 / 19.97
|
| PEG or PE/Growth / Sector |
0.92 / 1.22
|
| Average 1M Daily Value |
2.32 M
GREAT
|
| Average 1W Daily Value |
2.52 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
43% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:37 |
| Symbol | CDXS |
| Name | CODEXIS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 107.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 159.19 / 9,903.94 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 200 Penobscot Drive, Redwood City, CA, United States, 94063
Phone: 650 421 8100
Website: https://www.codexis.com
Employees: 146
Sector: Healthcare >> Biotechnology
Description: Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
